drugset / Trial / NCT01276990
Safety and Pharmacokinetics of Multiple Rising Oral Doses of BI 224436 in Healthy Male Volunteers.
RandomizedParallel-groupDouble-blindTreatment
Summary
To investigate the safety and pharmacokinetic of BI 224436 in healthy male volunteers following oral administration of repeated doses for 10 days within 8 dosing regimens.
Timeline
- Start
- 2011-01
- Primary completion
- 2012-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 224436 | Small molecule | 12.5 mg | Oral |
| Subject | BI 224436 | Small molecule | 25 mg | Oral |
| Subject | BI 224436 | Small molecule | 37.5 mg | Oral |
| Subject | BI 224436 | Small molecule | 50 mg | Oral |